BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31414748)

  • 1. Potential Diagnostic Value of Plasma Long-Chain Non-Coding RNA HIT in Breast Cancer.
    Hou H; Li F; Yang W; Wang H
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
    Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
    Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
    Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
    Zhao T; Wu L; Li X; Dai H; Zhang Z
    Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
    Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
    Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.
    Xu N; Chen F; Wang F; Lu X; Wang X; Lv M; Lu C
    Tumour Biol; 2015 Sep; 36(10):7659-65. PubMed ID: 25929808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
    Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
    Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
    Li W; Li N; Kang X; Shi K
    Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
    Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
    Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection.
    Yin WB; Yan MG; Fang X; Guo JJ; Xiong W; Zhang RP
    Clin Chim Acta; 2018 Dec; 487():363-368. PubMed ID: 29045858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer.
    Huang M; He YR; Liang LC; Huang Q; Zhu ZQ
    World J Gastroenterol; 2017 Sep; 23(34):6330-6338. PubMed ID: 28974900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
    Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
    Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
    Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
    Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
    Zhao W; Song M; Zhang J; Kuerban M; Wang H
    Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer.
    Wang M; Liu H; Wu W; Zhao J; Song G; Chen X; Wang R; Shao C; Li J; Wang H; Wang Q; Feng X
    Clin Breast Cancer; 2022 Feb; 22(2):e135-e141. PubMed ID: 34119428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
    Miao Y; Fan R; Chen L; Qian H
    Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.